1073160-26-5 Usage
Uses
Used in Pharmaceutical Industry:
PF 04554878 hydrochloride is used as a therapeutic agent for the treatment of various conditions, including chronic pain, inflammation, and psychiatric disorders. Its ability to modulate endocannabinoid signaling offers a potential avenue for managing these conditions with reduced side effects compared to traditional treatments.
Used in Pain Management:
PF 04554878 hydrochloride is used as an analgesic agent to alleviate chronic pain by increasing the levels of anandamide, which interacts with the endocannabinoid system to produce pain-relieving effects.
Used in Inflammation Control:
PF 04554878 hydrochloride is used as an anti-inflammatory agent to reduce inflammation by modulating the endocannabinoid system, which plays a role in the body's inflammatory response.
Used in Psychiatric Disorders Treatment:
PF 04554878 hydrochloride is used as a psychiatric treatment to address various mental health conditions by leveraging the endocannabinoid system's influence on mood, anxiety, and other cognitive functions.
Used in Drug Development Research:
PF 04554878 hydrochloride is used as a research tool in the development of new medications targeting the endocannabinoid system for a range of therapeutic applications, given its high selectivity and favorable safety profile.
Check Digit Verification of cas no
The CAS Registry Mumber 1073160-26-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,7,3,1,6 and 0 respectively; the second part has 2 digits, 2 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1073160-26:
(9*1)+(8*0)+(7*7)+(6*3)+(5*1)+(4*6)+(3*0)+(2*2)+(1*6)=115
115 % 10 = 5
So 1073160-26-5 is a valid CAS Registry Number.
1073160-26-5Relevant articles and documents
SULFONYL AMIDE DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELL GROWTH
-
Page/Page column 53, (2009/04/24)
The present invention relates to a compound of the formula I wherein R1 to R6, A, B, n and m are as defined herein. Such novel sulfonyl amide derivatives are useful in the treatment of abnormal cell growth, such as cancer, in mammals. This invention also relates to a method of using such compounds in the treatment of abnormal cell growth in mammals, especially humans, and to pharmaceutical compositions containing such compounds.